Natural Killer Cell Education and Tolerance

Cell

Volumn 142, Issue 6, 2010, Pages 847-856

  Orr, Mark T ^a   Lanier, Lewis L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR; AUTOANTIGEN; HLA ANTIGEN CLASS 1;

AUTOIMMUNITY; CLONAL ANERGY; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOLOGICAL TOLERANCE; LEUKEMIA; LONG TERM EXPOSURE; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; IMMUNOLOGY; METABOLISM;

ANIMALS; AUTOANTIGENS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNE TOLERANCE; KILLER CELLS, NATURAL; RECEPTORS, NATURAL KILLER CELL;

EID: 77956642196     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2010.08.031     Document Type: Review

References (87)

1. Abi-Rached L., Parham P. Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues. J. Exp. Med. 2005, 201:1319-1332.
2. Andersson K.E., Williams G.S., Davis D.M., Hoglund P. Quantifying the reduction in accessibility of the inhibitory NK cell receptor Ly49A caused by binding MHC class I proteins in cis. Eur. J. Immunol. 2007, 37:516-527.
3. Andrews D.M., Estcourt M.J., Andoniou C.E., Wikstrom M.E., Khong A., Voigt V., Fleming P., Tabarias H., Hill G.R., van der Most R.G., et al. Innate immunity defines the capacity of antiviral T cells to limit persistent infection. J. Exp. Med. 2010, 207:1333-1343.
4. Anfossi N., Andre P., Guia S., Falk C.S., Roetynck S., Stewart C.A., Breso V., Frassati C., Reviron D., Middleton D., et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity 2006, 25:331-342.
5. Arase H., Mocarski E.S., Campbell A.E., Hill A.B., Lanier L.L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 2002, 296:1323-1326.
6. Back J., Malchiodi E.L., Cho S., Scarpellino L., Schneider P., Kerzic M.C., Mariuzza R.A., Held W. Distinct conformations of Ly49 natural killer cell receptors mediate MHC class I recognition in trans and cis. Immunity 2009, 31:598-608.
7. Barber D.L., Wherry E.J., Masopust D., Zhu B., Allison J.P., Sharpe A.H., Freeman G.J., Ahmed R. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006, 439:682-687.
8. Bix M., Liao N.S., Zijlstra M., Loring J., Jaenisch R., Raulet D. Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice. Nature 1991, 349:329-331.
9. Brodin P., Karre K., Hoglund P. NK cell education: not an on-off switch but a tunable rheostat. Trends Immunol. 2009, 30:143-149.
10. Carlyle J.R., Mesci A., Fine J.H., Chen P., Belanger S., Tai L.H., Makrigiannis A.P. Evolution of the Ly49 and Nkrp1 recognition systems. Semin. Immunol. 2008, 20:321-330.
11. Cerwenka A., Baron J.L., Lanier L.L. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc. Natl. Acad. Sci. USA 2001, 98:11521-11526.
12. Chalifour A., Scarpellino L., Back J., Brodin P., Devevre E., Gros F., Levy F., Leclercq G., Hoglund P., Beermann F., et al. A role for cis interaction between the inhibitory Ly49A receptor and MHC class I for natural killer cell education. Immunity 2009, 30:337-347.
13. Champsaur M., Lanier L.L. Effect of NKG2D ligand expression on host immune responses. Immunol. Rev. 2010, 235:267-285.
14. Champsaur M., Beilke J.N., Ogasawara K., Koszinowski U.H., Jonjic S., Lanier L.L. Intact NKG2D-independent function of NK cells chronically stimulated with the NKG2D ligand Rae-1. J. Immunol. 2010, 185:157-165.
15. Chapman T.L., Heikeman A.P., Bjorkman P.J. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. Immunity 1999, 11:603-613.
16. Clausen J., Wolf D., Petzer A.L., Gunsilius E., Schumacher P., Kircher B., Gastl G., Nachbaur D. Impact of natural killer cell dose and donor killer-cell immunoglobulin-like receptor (KIR) genotype on outcome following human leucocyte antigen-identical haematopoietic stem cell transplantation. Clin. Exp. Immunol. 2007, 148:520-528.
17. Coudert J.D., Scarpellino L., Gros F., Vivier E., Held W. Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways. Blood 2008, 111:3571-3578.
18. Diefenbach A., Jensen E.R., Jamieson A.M., Raulet D.H. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 2001, 413:165-171.
19. Dokun A.O., Kim S., Smith H.R., Kang H.S., Chu D.T., Yokoyama W.M. Specific and nonspecific NK cell activation during virus infection. Nat. Immunol. 2001, 2:951-956.
20. Dong Z., Cruz-Munoz M.E., Zhong M.C., Chen R., Latour S., Veillette A. Essential function for SAP family adaptors in the surveillance of hematopoietic cells by natural killer cells. Nat. Immunol. 2009, 10:973-980.
21. Dorfman J.R., Zerrahn J., Coles M.C., Raulet D.H. The basis for self-tolerance of natural killer cells in beta2-microglobulin- and TAP-1- mice. J. Immunol. 1997, 159:5219-5225.
22. Doucey M.A., Scarpellino L., Zimmer J., Guillaume P., Luescher I.F., Bron C., Held W. Cis association of Ly49A with MHC class I restricts natural killer cell inhibition. Nat. Immunol. 2004, 5:328-336.
23. Fernandez N.C., Treiner E., Vance R.E., Jamieson A.M., Lemieux S., Raulet D.H. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 2005, 105:4416-4423.
24. Feuerer M., Shen Y., Littman D.R., Benoist C., Mathis D. How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets. Immunity 2009, 31:654-664.
25. Gasser S., Raulet D.H. Activation and self-tolerance of natural killer cells. Immunol. Rev. 2006, 214:130-142.
26. George T.C., Ortaldo J.R., Lemieux S., Kumar V., Bennett M. Tolerance and alloreactivity of the Ly49D subset of murine NK cells. J. Immunol. 1999, 163:1859-1867.
27. Gur C., Porgador A., Elboim M., Gazit R., Mizrahi S., Stern-Ginossar N., Achdout H., Ghadially H., Dor Y., Nir T., et al. The activating receptor NKp46 is essential for the development of type 1 diabetes. Nat. Immunol. 2010, 11:121-128.
28. Hanke T., Takizawa H., McMahon C.W., Busch D.H., Pamer E.G., Miller J.D., Altman J.D., Liu Y., Cado D., Lemonnier F.A., et al. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity 1999, 11:67-77.
29. Hanke T., Takizawa H., Raulet D.H. MHC-dependent shaping of the inhibitory Ly49 receptor repertoire on NK cells: evidence for a regulated sequential model. Eur. J. Immunol. 2001, 31:3370-3379.
30. Held W., Raulet D.H. Ly49A transgenic mice provide evidence for a major histocompatibility complex-dependent education process in natural killer cell development. J. Exp. Med. 1997, 185:2079-2088.
31. Held W., Dorfman J.R., Wu M.F., Raulet D.H. Major histocompatibility complex class I-dependent skewing of the natural killer cell Ly49 receptor repertoire. Eur. J. Immunol. 1996, 26:2286-2292.
32. Hsu K.C., Keever-Taylor C.A., Wilton A., Pinto C., Heller G., Arkun K., O'Reilly R.J., Horowitz M.M., Dupont B. Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. Blood 2005, 105:4878-4884.
33. Johansson M.H., Bieberich C., Jay G., Karre K., Hoglund P. Natural killer cell tolerance in mice with mosaic expression of major histocompatibility complex class I transgene. J. Exp. Med. 1997, 186:353-364.
34. Joncker N.T., Fernandez N.C., Treiner E., Vivier E., Raulet D.H. NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: the rheostat model. J. Immunol. 2009, 182:4572-4580.
35. Jonsson A.H., Yokoyama W.M. Natural killer cell tolerance licensing and other mechanisms. Adv. Immunol. 2009, 101:27-79.
36. Jonsson A.H., Yang L., Kim S., Taffner S.M., Yokoyama W.M. Effects of MHC class I alleles on licensing of Ly49A+ NK cells. J. Immunol. 2010, 184:3424-3432.
37. Kim S., Poursine-Laurent J., Truscott S.M., Lybarger L., Song Y.J., Yang L., French A.R., Sunwoo J.B., Lemieux S., Hansen T.H., et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 2005, 436:709-713.
38. Kulkarni S., Martin M.P., Carrington M. The Yin and Yang of HLA and KIR in human disease. Semin. Immunol. 2008, 20:343-352.
39. Kumar V., McNerney M.E. A new self: MHC-class-I-independent natural-killer-cell self-tolerance. Nat. Rev. Immunol. 2005, 5:363-374.
40. Lanier L.L. NK cell recognition. Annu. Rev. Immunol. 2005, 23:225-274.
41. Lanier L.L. Up on the tightrope: natural killer cell activation and inhibition. Nat. Immunol. 2008, 9:495-502.
42. Liao N.S., Bix M., Zijlstra M., Jaenisch R., Raulet D. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science 1991, 253:199-202.
43. Ljunggren H.G., Van Kaer L., Ploegh H.L., Tonegawa S. Altered natural killer cell repertoire in Tap-1 mutant mice. Proc. Natl. Acad. Sci. USA 1994, 91:6520-6524.
44. Lodoen M., Ogasawara K., Hamerman J.A., Arase H., Houchins J.P., Mocarski E.S., Lanier L.L. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J. Exp. Med. 2003, 197:1245-1253.
45. Lodoen M.B., Abenes G., Umamoto S., Houchins J.P., Liu F., Lanier L.L. The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60-NKG2D interactions. J. Exp. Med. 2004, 200:1075-1081.
46. Long E.O. Negative signaling by inhibitory receptors: the NK cell paradigm. Immunol. Rev. 2008, 224:70-84.
47. Lu L., Ikizawa K., Hu D., Werneck M.B., Wucherpfennig K.W., Cantor H. Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway. Immunity 2007, 26:593-604.
48. Martin M.P., Nelson G., Lee J.H., Pellett F., Gao X., Wade J., Wilson M.J., Trowsdale J., Gladman D., Carrington M. Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. J. Immunol. 2002, 169:2818-2822.
49. Miller J.S., Cooley S., Parham P., Farag S.S., Verneris M.R., McQueen K.L., Guethlein L.A., Trachtenberg E.A., Haagenson M., Horowitz M.M., et al. Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT. Blood 2007, 109:5058-5061.
50. Moretta A., Bottino C., Vitale M., Pende D., Cantoni C., Mingari M.C., Biassoni R., Moretta L. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 2001, 19:197-223.
51. Namekawa T., Snyder M.R., Yen J.H., Goehring B.E., Leibson P.J., Weyand C.M., Goronzy J.J. Killer cell activating receptors function as costimulatory molecules on CD4+CD28null T cells clonally expanded in rheumatoid arthritis. J. Immunol. 2000, 165:1138-1145.
52. Ogasawara K., Benjamin J., Takaki R., Phillips J.H., Lanier L.L. Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts. Nat. Immunol. 2005, 6:938-945.
53. Oppenheim D.E., Roberts S.J., Clarke S.L., Filler R., Lewis J.M., Tigelaar R.E., Girardi M., Hayday A.C. Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Nat. Immunol. 2005, 6:928-937.
54. Orr M.T., Murphy W.J., Lanier L.L. 'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection. Nat. Immunol. 2010, 11:321-327.
55. Parham P. The genetic and evolutionary balances in human NK cell receptor diversity. Semin. Immunol. 2008, 20:311-316.
56. Poirot L., Benoist C., Mathis D. Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity. Proc. Natl. Acad. Sci. USA 2004, 101:8102-8107.
57. Raulet D.H., Vance R.E. Self-tolerance of natural killer cells. Nat. Rev. Immunol. 2006, 6:520-531.
58. Raulet D.H., Held W., Correa I., Dorfman J.R., Wu M.F., Corral L. Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunol. Rev. 1997, 155:41-52.
59. Robbins S.H., Tessmer M.S., Mikayama T., Brossay L. Expansion and contraction of the NK cell compartment in response to murine cytomegalovirus infection. J. Immunol. 2004, 173:259-266.
60. Roth C., Carlyle J.R., Takizawa H., Raulet D.H. Clonal acquisition of inhibitory Ly49 receptors on developing NK cells is successively restricted and regulated by stromal class I MHC. Immunity 2000, 13:143-153.
61. Ruggeri L., Capanni M., Urbani E., Perruccio K., Shlomchik W.D., Tosti A., Posati S., Rogaia D., Frassoni F., Aversa F., et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002, 295:2097-2100.
62. Salcedo M., Diehl A.D., Olsson-Alheim M.Y., Sundback J., Van Kaer L., Karre K., Ljunggren H.G. Altered expression of Ly49 inhibitory receptors on natural killer cells from MHC class I-deficient mice. J. Immunol. 1997, 158:3174-3180.
63. Scarpellino L., Oeschger F., Guillaume P., Coudert J.D., Levy F., Leclercq G., Held W. Interactions of Ly49 family receptors with MHC class I ligands in trans and cis. J. Immunol. 2007, 178:1277-1284.
64. Sentman C.L., Olsson M.Y., Karre K. Missing self recognition by natural killer cells in MHC class I transgenic mice. A 'receptor calibration' model for how effector cells adapt to self. Semin. Immunol. 1995, 7:109-119.
65. Shi F.D., Takeda K., Akira S., Sarvetnick N., Ljunggren H.G. IL-18 directs autoreactive T cells and promotes autodestruction in the central nervous system via induction of IFN-gamma by NK cells. J. Immunol. 2000, 165:3099-3104.
66. Shilling H.G., Young N., Guethlein L.A., Cheng N.W., Gardiner C.M., Tyan D., Parham P. Genetic control of human NK cell repertoire. J. Immunol. 2002, 169:239-247.
67. Smith H.R., Heusel J.W., Mehta I.K., Kim S., Dorner B.G., Naidenko O.V., Iizuka K., Furukawa H., Beckman D.L., Pingel J.T., et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. USA 2002, 99:8826-8831.
68. Sobecks R.M., Ball E.J., Maciejewski J.P., Rybicki L.A., Brown S., Kalaycio M., Pohlman B., Andresen S., Theil K.S., Dean R., et al. Survival of AML patients receiving HLA-matched sibling donor allogeneic bone marrow transplantation correlates with HLA-Cw ligand groups for killer immunoglobulin-like receptors. Bone Marrow Transplant. 2007, 39:417-424.
69. Su H.C., Nguyen K.B., Salazar-Mather T.P., Ruzek M.C., Dalod M.Y., Biron C.A. NK cell functions restrain T cell responses during viral infections. Eur. J. Immunol. 2001, 31:3048-3055.
70. Sun J.C., Lanier L.L. Cutting edge: viral infection breaks NK cell tolerance to " missing self" J. Immunol. 2008, 181:7453-7457.
71. Sun J.C., Lanier L.L. Tolerance of NK cells encountering their viral ligand during development. J. Exp. Med. 2008, 205:1819-1828.
72. Sun J.C., Beilke J.N., Lanier L.L. Adaptive immune features of natural killer cells. Nature 2009, 457:557-561.
73. Sykes M., Harty M.W., Karlhofer F.M., Pearson D.A., Szot G., Yokoyama W. Hematopoietic cells and radioresistant host elements influence natural killer cell differentiation. J. Exp. Med. 1993, 178:223-229.
74. Symons H.J., Leffell M.S., Rossiter N.D., Zahurak M., Jones R.J., Fuchs E.J. Improved survival with inhibitory killer immunoglobulin receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantation. Biol. Blood Marrow Transplant. 2010, 16:533-542.
75. Teague R.M., Sather B.D., Sacks J.A., Huang M.Z., Dossett M.L., Morimoto J., Tan X., Sutton S.E., Cooke M.P., Ohlen C., et al. Interleukin-15 rescues tolerant CD8+ T cells for use in adoptive immunotherapy of established tumors. Nat. Med. 2006, 12:335-341.
76. Tripathy S.K., Keyel P.A., Yang L., Pingel J.T., Cheng T.P., Schneeberger A., Yokoyama W.M. Continuous engagement of a self-specific activation receptor induces NK cell tolerance. J. Exp. Med. 2008, 205:1829-1841.
77. Valiante N.M., Phillips J.H., Lanier L.L., Parham P. Killer cell inhibitory receptor recognition of human leukocyte antigen (HLA) class I blocks formation of a pp36/PLC-gamma signaling complex in human natural killer (NK) cells. J. Exp. Med. 1996, 184:2243-2250.
78. Valiante N.M., Uhrberg M., Shilling H.G., Lienert-Weidenbach K., Arnett K.L., D'Andrea A., Phillips J.H., Lanier L.L., Parham P. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 1997, 7:739-751.
79. Wang L.L., Chu D.T., Dokun A.O., Yokoyama W.M. Inducible expression of the gp49B inhibitory receptor on NK cells. J. Immunol. 2000, 164:5215-5220.
80. Wiemann K., Mittrucker H.W., Feger U., Welte S.A., Yokoyama W.M., Spies T., Rammensee H.G., Steinle A. Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo. J. Immunol. 2005, 175:720-729.
81. Wu M.F., Raulet D.H. Class I-deficient hemopoietic cells and nonhemopoietic cells dominantly induce unresponsiveness of natural killer cells to class I-deficient bone marrow cell grafts. J. Immunol. 1997, 158:1628-1633.
82. Yawata M., Yawata N., Draghi M., Little A.M., Partheniou F., Parham P. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J. Exp. Med. 2006, 203:633-645.
83. Yawata M., Yawata N., Draghi M., Partheniou F., Little A.M., Parham P. MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response. Blood 2008, 112:2369-2380.
84. Yen J.H., Moore B.E., Nakajima T., Scholl D., Schaid D.J., Weyand C.M., Goronzy J.J. Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J. Exp. Med. 2001, 193:1159-1168.
85. Yokoyama W.M., Kim S. Licensing of natural killer cells by self-major histocompatibility complex class I. Immunol. Rev. 2006, 214:143-154.
86. Yokoyama W.M., Altfeld M., Hsu K.C. Natural killer cells: tolerance to self and innate immunity to viral infection and malignancy. Biol. Blood Marrow Transplant. 2010, 16:S97-S105.
87. Yu J., Venstrom J.M., Liu X.R., Pring J., Hasan R.S., O'Reilly R.J., Hsu K.C. Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantation. Blood 2009, 113:3875-3884.